As a result of the development of recent years, the Dorog plants have become fundamental to ensuring the supply of active ingredients for our Women's Healthcare portfolio. Two steroid plants with a high level of steroid chemistry knowledge, manufacturing experience and a special technical base serve the needs of our gynecological strategic pillar with an ever-widening product range.
The API for one of our best-known products, Panangin, is also manufactured in Dorog, as well as most of our generic portfolio and our prorietary antipsychotic.
With a headcount of 740 employees, Gedeon Richter Polska is engaged in the manufacturing of finished dosage drugs and solid form packaging (tablet, capsule). The product portfolio comprises gastrointestinal, cardiovascular and anti-inflammatory preparations. Polfa markets 32 brands in several presentations in Poland. Its major export markets are Russia, Belarus, Uzbekistan, Romania and the Ukraine.
Similar to the parent company, GR Polska is also involved in marketing, promotion and R&D as well.